Hence, in 3D cultures, BH3-mimetic combinations targeting MCL-1 plus BCL-XL were most effective at killing melanoma cells, consistent with our 2D culture experiments, suggesting that this could be an effective targeting strategy in vivo. This evidence concerns the gene MCL1 and melanoma.